The Idiopathic Intracranial Hypertension Treatment Trial
Michael Wall(University of Iowa), Michael McDermott(University of Leeds), Karl Kieburtz(University of Rochester), Eleanor Schron(National Institutes of Health), Steven E. Feldon(University of Rochester), Mark J. Kupersmith, James J. Corbett(University of Delaware), Deborah I. Friedman(University of Rochester), John L. Keltner(Washington University in St. Louis), David M. Katz(Neurosciences Institute)
Cited by 475
Related Papers
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis
|New England Journal of Medicine|1992|1.3k
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
|Arthritis & Rheumatism|2004|743
Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
|New England Journal of Medicine|2003|655